- Home
- HKPD
as 06-20-2025 4:00pm EST
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
| Founded: | 2016 | Country: | Hong Kong |
| Employees: | N/A | City: | N/A |
| Market Cap: | 20.9M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.81 - $3.79 | Next Earning Date: | 01-01-0001 |
| Revenue: | $20,770,344 | Revenue Growth: | 32.91% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares News
HKPD Breaking Stock News: Dive into HKPD Ticker-Specific Updates for Smart Investing
GOBankingRates
21 days ago
7 Summer Side Hustles That Can Pay $1,000 a Week or More
Yahoo Finance Video
21 days ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
21 days ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
The Guardian
21 days ago
When are people too old to do their jobs?
GlobeNewswire
21 days ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
GlobeNewswire
21 days ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PR Newswire
21 days ago
Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
CNW Group
21 days ago
Statement by Minister Guilbeault on Portuguese Heritage Month
Compare HKPD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.